{"hq_id":"hq-p-bdy-000155","name":"Chemical Peel and At-Home Acid Products (Glycolic, Salicylic, TCA — pH Matters More Than Percentage, Barrier Damage, Photosensitivity)","category":{"primary":"body_care","secondary":"chemical_exfoliant","tags":["chemical peel","glycolic acid","salicylic acid","TCA","trichloroacetic acid","AHA","BHA","at-home peel","pH","free acid value","photosensitivity","barrier damage","exfoliant","acid toner"]},"product_tier":"BDY","overall_risk_level":"moderate","description":"At-home chemical exfoliation products have proliferated from professional-only peels into mass-market toners, serums, and masks containing alpha-hydroxy acids (AHAs: glycolic, lactic, mandelic), beta-hydroxy acids (BHAs: salicylic), and even medium-depth peel agents (TCA at 10-20%, previously physician-only). The critical safety factor is not percentage alone but free acid value (FAV), determined by concentration AND pH — a 10% glycolic acid product at pH 3.0 delivers approximately 6.3% free acid, while the same 10% at pH 3.8 delivers approximately 2.6% free acid. Products marketed as '30% AHA' at low pH can cause chemical burns equivalent to clinical peels. The CIR (Cosmetic Ingredient Review) panel set safety parameters: glycolic acid safe at concentrations up to 10% with pH >=3.5 in daily-use products (leave-on), up to 30% at pH >=3.0 in salon professional peels, and up to 70% at pH >=3.0 in physician-only peels. FDA received 100+ adverse event reports (2015-2022) for at-home acid products, including chemical burns, permanent scarring, and hyperpigmentation. AHAs increase UV sensitivity by 18% at 4% concentration (FDA 2005 photoprotection study), mandating sunscreen use during AHA treatment periods. TCA at concentrations above 20% causes controlled dermal coagulation — at-home TCA peels at 15-30% (sold on Amazon) lack professional oversight for depth control, creating scarring and infection risk.","synthesis":{"derived_risk_level":"low","synthesis_confidence":0.82,"synthesis_method":"compound_composition","context_used":"human_adult","context_source":"product_users","exposure_modifier":1.026,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":3,"compounds_total":3,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"individuals with rosacea or sensitive skin (AHA exacerbation), Fitzpatrick skin types IV-VI (post-inflammatory hyperpigmentation from chemical burns), individuals on retinoid therapy (compounded barrier disruption), pregnancy (salicylic acid use debated, TCA contraindicated)","overall_risk":"moderate","primary_concerns":["pH determines free acid value — percentage alone is misleading for safety","At-home TCA peels at 15-30% sold without professional oversight — scarring risk","AHAs increase UV sensitivity by 18% — photodamage without sunscreen","FDA received 100+ adverse event reports for at-home acid products (2015-2022)"],"exposure_routes":"Dermal (direct application of acidic solutions to facial and body skin — pH-dependent penetration depth and tissue effect)"},"exposure":{"routes":["dermal"],"contact_types":["skin_prolonged","skin_brief"],"users":["adult"],"duration":"minutes","frequency":"daily","scenarios":["Daily glycolic acid toner at 5-10% pH 3.5: mild exfoliation — photosensitivity increase","Weekly at-home AHA peel at 20-30%: barrier disruption, 1-3 day recovery","At-home TCA peel at 15-30%: controlled chemical burn — scarring risk without professional oversight","Layering multiple acid products: cumulative free acid exceeds safe levels"],"notes":"Free acid value (FAV): determines biological activity of AHAs. FAV = f(concentration, pH, pKa). Glycolic acid pKa 3.83. At pH 3.0: ~63% of glycolic is in free acid (active) form. At pH 4.0: ~40% free acid. pH matters more than percentage for efficacy AND safety. CIR safety parameters: daily leave-on: <=10% AHA, pH >=3.5. Salon peel: <=30%, pH >=3.0. Physician peel: <=70%, pH >=3.0. EU Cosmetics Regulation: glycolic acid limited to 4% in leave-on consumer products (Annex III Entry 218). FDA 2005 study: AHAs increase UV sensitivity by 18% at 4% concentration — sun protection mandatory. Salicylic acid: limited to 2% OTC in US (acne drug monograph 21 CFR 333.310), up to 3% in EU cosmetics. TCA (trichloroacetic acid): not an AHA — causes protein coagulation (medium-depth peel). 15-20% TCA causes epidermal peeling. 20-35% TCA reaches papillary dermis. Above 35%: reticular dermis — high scarring risk. At-home TCA peels sold online at 15-30% — no physician oversight, no skin type assessment, no aftercare protocol. FDA adverse events: 100+ reports for at-home acid products (2015-2022)."},"consumer_guidance":{"usage_warning":"Start with low-concentration, higher-pH products and gradually increase. For daily use, glycolic acid should not exceed 10% at pH >=3.5 (CIR recommendation). Always use SPF 30+ sunscreen during AHA/BHA treatment periods — AHAs increase UV sensitivity by 18%. Do not layer multiple acid products (glycolic toner + salicylic serum + retinol = compounded barrier damage). Do not purchase at-home TCA peels above 15% — medium-depth peels require in-person physician assessment for skin type, depth control, and aftercare. If chemical burn occurs (persistent whiteness, deep redness, blistering), flush with cool water and seek medical attention — do not apply neutralizer to TCA burns. Avoid acid exfoliation for 1-2 weeks before and after professional treatments (laser, microdermabrasion, waxing).","safer_alternatives":["PHAs (polyhydroxy acids — gluconolactone, lactobionic acid) — larger molecule, gentler, humectant properties","Enzyme exfoliants (papain, bromelain) — pH-neutral, no photosensitivity increase","Low-strength mandelic acid (larger molecule AHA — slower penetration, less irritation)","Professional in-office peels with physician oversight for medium-depth treatments"]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA OTC Drug Monograph (Salicylic Acid) + CIR AHA Safety Assessment + MoCRA (2022)","citation":"21 CFR 333.310 (salicylic acid OTC acne); CIR Final Report on AHAs (2013); FDA MoCRA (2022); FDA Consumer Alert on AHAs (2005)","requirements":"Salicylic acid: FDA OTC drug monograph limits to 0.5-2% for acne treatment (21 CFR 333.310). Glycolic acid: no FDA concentration limit — CIR recommends <=10% at pH >=3.5 for daily consumer use. FDA 2005: required SPF labeling advisory on AHA-containing products (sunburn alert). TCA: not an OTC drug ingredient — no FDA monograph. At-home TCA peels occupy regulatory gap (not clearly cosmetic or drug). MoCRA (2022): adverse event reporting required for cosmetic acid products.","compliance_status":null,"effective_date":null,"enforcing_agency":"FDA / CIR (industry self-regulation)","penalties":null,"source_ref":null},{"jurisdiction":"EU","regulation":"EU Cosmetics Regulation 1223/2009 — AHA/BHA Restrictions","citation":"Regulation (EC) No 1223/2009, Annex III Entry 218 (glycolic acid); Annex III Entry 98 (salicylic acid)","requirements":"Glycolic acid: max 4% in leave-on consumer cosmetics (Annex III Entry 218). Salicylic acid: max 2% in rinse-off, 3% in other cosmetics (Annex III Entry 98), not for use in products for children under 3 (except shampoo). Higher concentrations (salon/professional peels): must carry warning 'For professional use only' and include directions/pH requirements. SCCS provides safety opinions on individual acids. TCA: not specifically addressed in Annex III — professional medical use only in EU practice.","compliance_status":null,"effective_date":"2013-07-11","enforcing_agency":"EU Member State competent authorities / SCCS","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":true,"disposal_guidance":"Dispose product containers per local recycling guidelines. Unused acid products at high concentration (>20%): dilute with water before pouring down drain, or take to household hazardous waste collection. Do not mix acid products with bleach-containing cleaners (chlorine gas generation risk with some formulations).","hazardous_waste":false,"expected_lifespan":"6-18 months (acids degrade over time — efficacy decreases, pH may shift)"},"formulation":{"form":"varies","key_ingredients":[],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000447","compound_name":null,"role":"active_exfoliant","typical_concentration":"2-70% glycolic acid (pH-dependent free acid value determines biological activity)"},{"hq_id":"hq-c-org-000313","compound_name":null,"role":"active_exfoliant","typical_concentration":"0.5-2% in daily products, 10-30% in peels (oil-soluble, penetrates pores)"},{"hq_id":"hq-c-org-000230","compound_name":null,"role":"medium_depth_peel_agent","typical_concentration":"10-35% TCA (physician-only above 20%, but sold at-home at 15-30%)"}],"identifiers":{"common_names":["chemical peel and at-home acid products (glycolic, salicylic, tca — ph matters more than percentage, barrier damage, photosensitivity)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"Johnson & Johnson","manufacturer":"J&J","market_position":"mass_market","notable":"Broad personal care portfolio"},{"brand":"Unilever","manufacturer":"Unilever","market_position":"mass_market","notable":"Global personal care conglomerate"},{"brand":"Procter & Gamble","manufacturer":"P&G","market_position":"mass_market","notable":"Personal care market leader"}],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-26"},{"type":"regulation","title":"FDA OTC Drug Monograph (Salicylic Acid) + CIR AHA Safety Assessment + MoCRA (2022) (21 CFR 333.310 (salicylic acid OTC acne); CIR Final Report on AHAs (2013); FDA MoCRA (2022); FDA Consumer Alert on AHAs (2005))","jurisdiction":"USA","citation":"21 CFR 333.310 (salicylic acid OTC acne); CIR Final Report on AHAs (2013); FDA MoCRA (2022); FDA Consumer Alert on AHAs (2005)","id":"src_b48f2183"},{"type":"regulation","title":"EU Cosmetics Regulation 1223/2009 — AHA/BHA Restrictions (Regulation (EC) No 1223/2009, Annex III Entry 218 (glycolic acid); Annex III Entry 98 (salicylic acid))","jurisdiction":"EU","year":2013,"citation":"Regulation (EC) No 1223/2009, Annex III Entry 218 (glycolic acid); Annex III Entry 98 (salicylic acid)","id":"src_86715257"},{"id":"epa_glycolic_acid_2000","type":"regulatory","title":"US EPA Glycolic Acid: Group D Not Classifiable; Alpha-Hydroxy Acid Natural Occurrence Sugarcane; FDA AHA Safety Guidelines 2005 Maximum 10% pH ≥3.5; Photosensitivity from Stratum Corneum Thinning; Professional Peel Burn Risk; Highly Biodegradable","year":2000,"inherited_from_compound":"hq-c-org-000447"},{"id":"efsa_sccs_aha_2005","type":"regulatory","title":"EFSA/SCCS Glycolic Acid/AHAs: EU Leave-On Maximum 10% Rinse-Off 4%; pH Minimum 3.5 Requirement; Mandatory Sunscreen Advice; Small MW 76 g/mol High Penetration; Collagen Stimulation; Rosacea/Eczema Exacerbation Concern; Excellent Aquatic Biodegradability","year":2005,"inherited_from_compound":"hq-c-org-000447"},{"id":"fda_salicylic_acid_otc_2019","type":"regulatory","title":"FDA OTC Monograph: Salicylic Acid — acne (0.5–2%); wart removal (up to 40%); dandruff (1.8–3%); Reye's syndrome warning; systemic absorption from large-area application; methyl salicylate poisoning (2019)","year":2019,"inherited_from_compound":"hq-c-org-000313"},{"id":"niosh_salicylic_acid_2019","type":"regulatory","title":"NIOSH: Salicylic Acid — keratolytic mechanism; dermal absorption ~25%; salicylism at high serum levels; topical analgesic products; aspirin relationship; pediatric precautions (2019)","year":2019,"inherited_from_compound":"hq-c-org-000313"},{"id":"iarc_haa_v84_2004","type":"regulatory","title":"IARC Monographs Volume 84: Some Drinking-water Disinfectants and Contaminants, Including Arsenic — Dichloroacetic Acid Group 2A, Trichloroacetic Acid Group 3, MX Group 2B (2004)","year":2004,"inherited_from_compound":"hq-c-org-000230"},{"id":"epa_stage2_dbpr_2006","type":"regulatory","title":"US EPA: Stage 2 Disinfectants and Disinfection Byproducts Rule (40 CFR Parts 141 and 142) — TTHM MCL 80 μg/L, HAA5 MCL 60 μg/L, Locational Running Annual Average, BDCM Cancer Risk Assessment, Bladder Cancer Epidemiology (2006)","year":2006,"inherited_from_compound":"hq-c-org-000230"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-26","timestamp":"2026-05-02T18:17:41.862Z"}}